A Safety Study of Intravenous Immunoglobulin in Patients With Chronic Immune Thrombocytopenic Purpura (ITP)

Clinical trial NCT01390649 · COMPLETED

Trial details

NCT number: NCT01390649
Sponsor: CSL Behring
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Immune Thrombocytopenic Purpura

Start date: 2011-11-01
Primary completion: 2014-09-01
Enrollment: 57

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.